1. Garcia-Hermoso D, Dannaoui E, Lortholary O, Dromer F. Agents of systemic and subcutaneous mucormycosis and entomophthoromycosis. In : Versalovic J, Carroll KC, Funke G, Jorgensen JH, Landry ML, Warnock DW, editors. Manual of clinical microbiology. 10th ed. Washington, DC: ASM press;2011. p. 1880–1901.
2. Ibrahim AS, Spellberg B, Walsh TJ, Kontoyiannis DP. Pathogenesis of mucormycosis. Clin Infect Dis. 2012; 54(Suppl 1):S16–S22. PMID:
22247441.
Article
3. Hamilos G, Samonis G, Kontoyiannis DP. Pulmonary mucormycosis. Semin Respir Crit Care Med. 2011; 32:693–702. PMID:
22167397.
Article
4. Ribes JA, Vanover-Sams CL, Baker DJ. Zygomycetes in human disease. Clin Microbiol Rev. 2000; 13:236–301. PMID:
10756000.
Article
5. Schwarz P, Bretagne S, Gantier JC, Garcia-Hermoso D, Lortholary O, Dromer F, et al. Molecular identification of zygomycetes from culture and experimentally infected tissues. J Clin Microbiol. 2006; 44:340–349. PMID:
16455881.
Article
6. Park Y. Sequence analysis of the internal transcribed spacer of ribosomal DNA in the genus
Rhizopus. Mycobiology. 2005; 33:109–112. PMID:
24049483.
7. Kontoyiannis DP, Lionakis MS, Lewis RE, Chamilos G, Healy M, Perego C, et al. Zygomycosis in a tertiary-care cancer center in the era of Aspergillus-active antifungal therapy: a case-control observational study of 27 recent cases. J Infect Dis. 2005; 191:1350–1360. PMID:
15776383.
8. Roden MM, Zaoutis TE, Buchanan WL, Knudsen TA, Sarkisova TA, Schaufele RL, et al. Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis. 2005; 41:634–653. PMID:
16080086.
Article
9. Garg J, Sujatha S, Garg A, Parija SC. Nosocomial cutaneous zygomycosis in a patient with diabetic ketoacidosis. Int J Infect Dis. 2009; 13:e508–e510. PMID:
19428282.
Article
10. de Mol P, Meis JF. Disseminated
Rhizopus microsporus infection in a patient on oral corticosteroid treatment: a case report. Neth J Med. 2009; 67:25–28. PMID:
19155544.
11. Vigouroux S, Morin O, Moreau P, Méchinaud F, Morineau N, Mahé B, et al. Zygomycosis after prolonged use of voriconazole in immunocompromised patients with hematologic disease: attention required. Clin Infect Dis. 2005; 40:e35–e37. PMID:
15712069.
Article
12. Balajee SA, Borman AM, Brandt ME, Cano J, Cuenca-Estrella M, Dannaoui E, et al. Sequence-based identification of aspergillus, fusarium, and mucorales species in the clinical mycology laboratory: where are we and where should we go from here? J Clin Microbiol. 2009; 47:877–884. PMID:
19073865.
13. Alvarez E, Sutton DA, Cano J, Fothergill AW, Stchigel A, Rinaldi MG, et al. Spectrum of zygomycete species identified in clinically significant specimens in the United States. J Clin Microbiol. 2009; 47:1650–1656. PMID:
19386856.
Article